Insufficient ErbB signalling is associated with the development of neurodegenerative diseases, while excessive ErbB signalling is associated with the development of a wide variety of types of solid tumour.
Insufficient ErbB signalling is associated with the development of neurodegenerative diseases. Excessive ErbB signalling is associated with the development of a wide variety of types of solid tumour.